0
ARTICLE |

PHENETHYLBIGUANIDE, A NEW ORALLY GIVEN HYPOGLYCEMIC AGENT:  REPORT AFTER TWO YEARS OF CLINICAL EXPERIENCE

Julius Pomeranze, M.D.; George T. Mouratoff, M.D.; Raymond J. Gadek, M.D.; Edward J. King, M.D.
JAMA. 1959;171(3):252-258. doi:10.1001/jama.1959.03010210004002.
Text Size: A A A
Published online

Phenethylbiguanide (DBI) has been used for its hypoglycemic action in the treatment of diabetes mellitus in 206 patients for a period of two years. Adequacy of management, maintained in 128 patients, was judged by the absence of diabetic symptoms and of the drug's side-effects (nausea, anorexia, and gastrointestinal disturbances). DBI made exogenous insulin unnecessary in 110 patients who were known to have a partial supply of insulin from their pancreas. The exogenous insulin requirement was decreased one-half when 18 patients who produced no natural insulin were given DBI. Severe gastrointestinal intolerance to DBI forced 53 patients to stop taking it, but recovery from untoward effects was complete in every case. During the two-year administration there were no signs or symptoms in any of the 206 patients indicative of tissue damage due to DBI.

Topics

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

Figures

Tables

References

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();